The MUC5B Promoter Variant does not Predict Progression of Interstitial Lung Disease in Systemic Sclerosis

OBJECTIVE: To investigate the prevalence of the MUC5B promoter variant rs35705950 in patients with systemic sclerosis-interstitial lung disease (SSc-ILD) and whether its presence predicts response to immunosuppression with cyclophosphamide (CYC) and mycophenolate (MMF). METHODS: SSc-ILD patients who...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Semin Arthritis Rheum
Main Authors: Volkmann, Elizabeth R., Tashkin, Donald P., Roth, Michael D., Li, Ning, Charles, Julio, Mayes, Maureen, Kim, Grace, Goldin, Jonathan, Pourzand, Lila, Clements, Philip J., Furst, Daniel E., Khanna, Dinesh, Elashoff, Robert M., Assassi, Shervin
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7584725/
https://ncbi.nlm.nih.gov/pubmed/32906032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semarthrit.2020.06.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados